Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0

If the merger is approved by the shareholders it is expected to close by the 3rd quarter of 2001. I hope shareholders approve. After doing my dd it seems to me that combining absc's drug evaluation techniques and expertise with vrtx's chemogenomic platform makes for a very compelling biotechnology investment.

For me, the evaluation of management expertise is one of the most difficult elements in the process of company evaluation. I view this particular initiative on the part of the management of both companies as bold, innovative and decisive. I like to see those characteristics in my management team. I'm really excited about the future of the new Vertex!
Print the post  

Announcements

When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.